Related by context. Frequent words. (Click for all words.) 66 axitinib 64 AACR NCI EORTC 64 CR# vcMMAE 63 PXD# 63 dose escalation trial 63 relapsed refractory multiple myeloma 63 phase IIb 63 Phase 1b clinical 62 phase IIa 62 Phase 1b 62 placebo controlled clinical 62 Phase 1b trial 62 XL# [003] 62 TRITON TIMI 61 tanespimycin 61 randomized Phase III 61 EORTC NCI AACR Symposium 61 Phase 2a trial 61 Phase 2a clinical 61 eculizumab 61 dose escalation 61 Pivotal Phase III 61 IMGN# 60 Phenoptin 60 Phase 1a 60 Phase Ib 60 rNAPc2 60 Phase 2b study 60 CYT# 60 ocrelizumab 60 HER2 positive metastatic breast 60 phase 2a 59 nab paclitaxel 59 RGB # 59 double blinded placebo 59 ponatinib 59 LymphoStat B 59 darapladib 59 pazopanib 59 SCH # 59 tolerated dose MTD 59 CA4P 59 EORTC 59 refractory multiple myeloma 58 angiogenesis inhibitor 58 HCV protease inhibitor 58 Phase 2a 58 GRN#L 58 neoadjuvant 58 Clinical Trial Results 58 Phase 2b clinical 58 secondary efficacy endpoints 58 Phase IIa trial 58 label dose escalation 58 OXi# 58 Phase Ia 58 CRx 58 dose cohorts 58 Phase IIa clinical 58 Azedra 58 AP# [003] 58 Pharmacokinetic 58 thymalfasin 58 laquinimod 58 ASCO Annual Meeting 58 romidepsin 58 prospective randomized controlled 58 HuMax CD# 58 Atiprimod 57 BCX# 57 Phase 2b trial 57 ELND# 57 HGS ETR1 57 Board DSMB 57 registrational 57 dose limiting toxicities 57 resistant ovarian cancer 57 Phase III randomized 57 PEG Interferon lambda 57 nitazoxanide 57 teduglutide 57 investigational compound 57 Solid Tumors 57 MGCD# [002] 57 Phase 2b 57 subgroup analyzes 57 TYKERB 57 vicriviroc 57 vandetanib 57 Asentar 57 LY# [003] 56 drug conjugate 56 decitabine 56 castration resistant prostate cancer 56 Neuradiab 56 sapacitabine 56 Clinical Oncology Annual Meeting 56 achieved statistical significance 56 Phase IIa 56 virologic 56 eltrombopag